NCT00258310 · OUTCOME
Overall Survival
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- Within 3 years of end of study
What was measured
Estimated time from study entry to death from any cause
Analysis population: Entire study population
Groups in this outcome
Capecitabine
Capecitabine 1000mg/day for one year capecitabine adjuvant therapy
| Group | Source count |
|---|---|
| Capecitabine | 33 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Capecitabine | NA | Not reported | NA | NA | Neither the median nor the 95% confidence interval can be calculated because there were too few deaths. |
Complete source fields
- classes
- categories
- measurements
- comment
- Neither the median nor the 95% confidence interval can be calculated because there were too few deaths.
- group Id
- OG000
- lower Limit
- NA
- upper Limit
- NA
- value
- NA
- denoms
- counts
- group Id
- OG000
- value
- 33
- units
- Participants
- description
- Estimated time from study entry to death from any cause
- dispersion Type
- 95% Confidence Interval
- groups
- description
- Capecitabine 1000mg/day for one year capecitabine adjuvant therapy
- id
- OG000
- title
- Capecitabine
- param Type
- MEDIAN
- population Description
- Entire study population
- reporting Status
- POSTED
- time Frame
- Within 3 years of end of study
- title
- Overall Survival
- type
- SECONDARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle